Pacific Edge Limited (PEB.AX)
AUD 0.14
(0.0%)
AUD 0.14
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 2.73 Million NZD | 0.0% |
| 2023 | 411 Thousand NZD | -51.7% |
| 2022 | 851 Thousand NZD | -52.19% |
| 2021 | 1.78 Million NZD | 211.73% |
| 2020 | 571 Thousand NZD | 1684.38% |
| 2019 | 32 Thousand NZD | 23.08% |
| 2018 | 26 Thousand NZD | 0.0% |
| 2017 | - NZD | 0.0% |
| 2016 | - NZD | 0.0% |
| 2015 | - NZD | 0.0% |
| 2014 | - NZD | 0.0% |
| 2013 | - NZD | 0.0% |
| 2012 | - NZD | 0.0% |
| 2011 | - NZD | 0.0% |
| 2010 | - NZD | 0.0% |
| 2009 | - NZD | 0.0% |
| 2008 | - NZD | -100.0% |
| 2007 | 10 Thousand NZD | -87.24% |
| 2006 | 78.35 Thousand NZD | 0.0% |
| 2005 | - NZD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 884 Thousand NZD | 0.0% |
| 2024 Q3 | 2.5 Million NZD | 183.82% |
| 2024 Q4 | 2.73 Million NZD | -100.0% |
| 2024 Q1 | 884 Thousand NZD | 0.0% |
| 2024 FY | 2.73 Million NZD | 565.5% |
| 2023 Q2 | 664 Thousand NZD | 0.0% |
| 2023 Q4 | 411 Thousand NZD | 0.0% |
| 2023 FY | 411 Thousand NZD | -51.7% |
| 2023 Q3 | 411 Thousand NZD | -38.1% |
| 2023 Q1 | 664 Thousand NZD | -21.97% |
| 2022 Q3 | 851 Thousand NZD | -35.29% |
| 2022 Q4 | 851 Thousand NZD | 0.0% |
| 2022 FY | 851 Thousand NZD | -52.19% |
| 2022 Q1 | 1.31 Million NZD | -26.12% |
| 2022 Q2 | 1.31 Million NZD | 0.0% |
| 2021 FY | 1.78 Million NZD | 211.73% |
| 2021 Q2 | 2.31 Million NZD | 0.0% |
| 2021 Q1 | 2.31 Million NZD | 304.9% |
| 2021 Q4 | 1.78 Million NZD | 0.0% |
| 2021 Q3 | 1.78 Million NZD | -23.01% |
| 2020 Q1 | 352 Thousand NZD | 1000.0% |
| 2020 Q4 | 571 Thousand NZD | 0.0% |
| 2020 Q2 | 352 Thousand NZD | 0.0% |
| 2020 Q3 | 571 Thousand NZD | 62.22% |
| 2020 FY | 571 Thousand NZD | 1684.38% |
| 2019 Q1 | 48 Thousand NZD | 84.62% |
| 2019 FY | 32 Thousand NZD | 23.08% |
| 2019 Q4 | 32 Thousand NZD | 0.0% |
| 2019 Q3 | 32 Thousand NZD | -33.33% |
| 2019 Q2 | 48 Thousand NZD | 0.0% |
| 2018 Q1 | 54 Thousand NZD | 0.0% |
| 2018 FY | 26 Thousand NZD | 0.0% |
| 2018 Q4 | 26 Thousand NZD | 0.0% |
| 2018 Q3 | 26 Thousand NZD | -51.85% |
| 2018 Q2 | 54 Thousand NZD | 0.0% |
| 2017 Q1 | - NZD | 0.0% |
| 2017 FY | - NZD | 0.0% |
| 2017 Q4 | - NZD | 0.0% |
| 2017 Q3 | - NZD | 0.0% |
| 2017 Q2 | - NZD | 0.0% |
| 2016 Q3 | - NZD | 0.0% |
| 2016 Q4 | - NZD | 0.0% |
| 2016 FY | - NZD | 0.0% |
| 2016 Q1 | - NZD | 0.0% |
| 2016 Q2 | - NZD | 0.0% |
| 2015 FY | - NZD | 0.0% |
| 2015 Q1 | - NZD | 0.0% |
| 2015 Q4 | - NZD | 0.0% |
| 2015 Q3 | - NZD | 0.0% |
| 2015 Q2 | - NZD | 0.0% |
| 2014 Q2 | - NZD | 0.0% |
| 2014 FY | - NZD | 0.0% |
| 2014 Q4 | - NZD | 0.0% |
| 2014 Q3 | - NZD | 0.0% |
| 2014 Q1 | - NZD | 0.0% |
| 2013 Q3 | - NZD | 0.0% |
| 2013 FY | - NZD | 0.0% |
| 2013 Q4 | - NZD | 0.0% |
| 2012 Q4 | - NZD | 0.0% |
| 2012 FY | - NZD | 0.0% |
| 2011 FY | - NZD | 0.0% |
| 2011 Q4 | - NZD | 0.0% |
| 2010 FY | - NZD | 0.0% |
| 2010 Q4 | - NZD | 0.0% |
| 2009 Q4 | - NZD | 0.0% |
| 2009 FY | - NZD | 0.0% |
| 2008 FY | - NZD | -100.0% |
| 2008 Q4 | - NZD | 0.0% |
| 2007 FY | 10 Thousand NZD | -87.24% |
| 2006 FY | 78.35 Thousand NZD | 0.0% |
| 2005 FY | - NZD | 0.0% |
| 2005 Q4 | - NZD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Australian Clinical Labs Limited | 55.06 Million AUD | 95.033% |
| BCAL Diagnostics Limited | 400.22 Thousand AUD | -583.423% |
| Genetic Signatures Limited | - AUD | -Infinity% |
| Genetic Technologies Limited | - AUD | -Infinity% |
| Healius Limited | 420.8 Million AUD | 99.35% |
| Imagion Biosystems Limited | 750 Thousand AUD | -264.693% |
| Integral Diagnostics Limited | 219.75 Million AUD | 98.755% |
| INOVIQ Ltd | - AUD | -Infinity% |
| Microba Life Sciences Limited | - AUD | -Infinity% |
| Monash IVF Group Limited | 59.56 Million AUD | 95.408% |
| Rhythm Biosciences Limited | - AUD | -Infinity% |
| Sonic Healthcare Limited | 2.69 Billion AUD | 99.898% |